| | Hang Seng Index | 26.440 HKD | +0.620 | +2.401% | 195.55M | 5.12B | 26.071 (+1.416%) HKD as at 2025/12/30 | | |
| | Hang Seng China Enterprises Index | 93.540 HKD | +2.280 | +2.498% | 42.28M | 3.93B | 92.157 (+1.501%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.610 HKD | +0.220 | +4.082% | 479.95M | 2.66B | 5.464 (+2.680%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.500 HKD | +0.395 | +7.738% | 176.26M | 947.94M | 5.240 (+4.954%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.336 HKD | -0.110 | -7.607% | 448.37M | 612.05M | 1.413 (-5.463%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.754 HKD | -0.086 | -4.674% | 134.67M | 239.55M | 1.802 (-2.675%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.140 HKD | +0.295 | +5.047% | 31.64M | 191.32M | 5.991 (+2.490%) HKD as at 2025/12/30 | | |
| | | 10.510 HKD | +0.090 | +0.864% | 15.24M | 159.84M | 10.466 (+0.417%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index (net total return version) | 12.000 HKD | +0.460 | +3.986% | 9.77M | 115.52M | 11.699 (+2.575%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.700 HKD | +0.215 | +3.920% | 17.82M | 100.42M | 5.555 (+2.610%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 17.140 HKD | +0.990 | +6.130% | 5.75M | 96.02M | 16.139 (+6.201%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.620 HKD | +0.060 | +0.307% | 2.15M | 42.17M | 19.669 (-0.250%) HKD as at 2025/12/30 | | |
| | | 9.350 HKD | +0.145 | +1.575% | 4.05M | 37.73M | 9.263 (+0.935%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 20.500 HKD | +0.080 | +0.392% | 1.41M | 28.87M | 20.595 (-0.460%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 36.140 HKD | +2.640 | +7.881% | 791.90K | 28.09M | 33.185 (+8.906%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 3,125.000 HKD | +13.000 | +0.418% | 6.75K | 21.05M | 398.810 (+0.596%) USD as at 2025/12/29 | | |
| | London Gold Fixing Price | 18.340 CNY | +0.020 | +0.109% | 1.07M | 19.72M | 18.483 (-0.772%) CNY as at 2025/12/30 | | |
| | CSI 300 Index | 54.040 HKD | +0.720 | +1.350% | 301.15K | 16.24M | 53.699 (+0.634%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises Index | 3.516 HKD | +0.116 | +3.412% | 2.99M | 10.36M | 3.426 (+2.621%) HKD as at 2025/12/30 | | |
| | FTSE China A50 Index | 16.570 HKD | +0.200 | +1.222% | 545.17K | 9.02M | 16.490 (+0.488%) HKD as at 2025/12/30 | | |
| | Hang Seng Biotech Index | 14.540 HKD | +0.190 | +1.324% | 613.70K | 8.88M | 14.515 (+0.174%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 26.840 HKD | +0.200 | +0.751% | 318.50K | 8.49M | 26.905 (-0.242%) HKD as at 2025/12/30 | | |
| | CSI 300 Index | 34.900 HKD | +0.200 | +0.576% | 210.40K | 7.31M | 34.743 (+0.452%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend Yield Index | 30.540 HKD | +0.140 | +0.461% | 234.31K | 7.14M | 30.441 (+0.326%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index | 8.270 HKD | +0.270 | +3.375% | 737.00K | 6.06M | 8.263 (+0.086%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.222 HKD | +0.002 | +0.062% | 1.79M | 5.79M | 3.201 (+0.672%) HKD as at 2025/12/30 | | |
| | NASDAQ-100 Index | 4,815.000 HKD | +5.000 | +0.104% | 1.08K | 5.18M | 620.870 (-0.438%) USD as at 2025/12/29 | | |
| | FTSE China A50 Index | 15.320 HKD | +0.200 | +1.323% | 326.21K | 4.98M | 15.286 (+0.221%) HKD as at 2025/12/30 | | |
| | | 10.920 HKD | +0.100 | +0.924% | 442.50K | 4.82M | 10.845 (+0.696%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average | 29.180 HKD | -0.400 | -1.352% | 162.34K | 4.79M | 29.738 (-1.877%) HKD as at 2025/12/30 | | |